Correction: MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis

This article has been corrected: Due to errors in image selection, two small pictures were partially overlapped in Figure 3A - the mimics-NC are the same as the inhibitor-NC in the migration group of 786-O. The corrected Figure 3 is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2015; 6:13201–13215. 13201-13215. https://doi.org/10.18632/oncotarget.3915

Figure 3. miR-1 attenuates ccRC cell migration and invasion.

(A. a) Migration and invasion assay for renal cancer cells. Representative photographs were taken at ×200 magnification; number of migrated cells was quantified in ten random images from each treatment group. (b) Results were the mean ± SEM from two independent experiments and plotted as percent (%) migrating cells relative to mimic-NC or inhibitor-NC. *P < 0.05. (B) EMT-related proteins were determined by immunoblot analysis. β-Tubulin was used as loading control. (C) Representative photographs of immunofluorescence were taken at ×200 magnification. ACHN cells were transfected with 100 nM of indicated small RNA molecules.